<DOC>
	<DOCNO>NCT01768117</DOCNO>
	<brief_summary>This study ass safety , tolerability immunogenicity bivalent rLP2086 vaccine laboratory worker ≥18 ≤65 year age administer Month 0 , 2 , 6 schedule . The study recruit laboratory personnel ( inclusive Pfizer staff ) work directly pathogenic Neisseria meningitidis context bivalent rLP2086 vaccine development program . The study provide descriptive safety immunogenicity data follow vaccination individual bivalent rLP2086 vaccine .</brief_summary>
	<brief_title>Study To Describe The Safety , Tolerability , And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<criteria>1 . Laboratory personnel ( inclusive Pfizer staff ) work directly pathogenic Neisseria meningitidis context bivalent rLP2086 vaccine development program . 2 . Male female subject age ≥18 ≤65 year time enrollment . 3 . Negative urine pregnancy test . 1 . Subjects receive allergen immunotherapy nonlicensed product receive allergen immunotherapy license product stable maintenance dos . 2 . A know suspected defect immune system would prevent immune response vaccine , subject congenital acquire defect B cell function receive immunosuppressive therapy . Subjects terminal complement deficiency exclude participation study . 3 . Significant neurological disorder history seizure ( exclude simple febrile seizure ) . 4 . Current chronic use systemic antibiotic . 5 . Received investigational drug , vaccine , device within 28 day administration first study vaccination . 6 . Any neuroinflammatory autoimmune condition , include , limited , transverse myelitis , uveitis , optic neuritis , multiple sclerosis . 7 . Prior receipt vaccine specifically target fHBP LP2086 antigen . 8 . History microbiologically proven disease cause Neisseria meningitidis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>